← Back to all trials
Enrolling By Invitation
NCT05659888
Comparison of Two Lipid Management Strategies in Very High Risk Patients
Conditions: Atherosclerotic Cardiovascular Disease, STEMI, Non STEMI
Sex: All
Ages: 18 Years – 70 Years
Enrollment: 700
Sponsor: Clinical Operations WCN B.V.
Location: Netherlands
Summary
Guideline recommended evidence-based clinical care correlates with improved patient outcomes.
In real life care, however, adherence to guideline recommendations remains suboptimal.
In real life, patients may receive suboptimal treatment and as a result treatment targets are not always met.
To support and improve secondary prevention for cardiovascular disease, PENELOPE and PENELOPE-CTRL are designed to support guideline implementation on lipid management and provide valuable feedback to care-givers on real world data.
Eligibility Criteria
Inclusion Criteria:Age >18 and ≤70 yearsAlive at hospital discharge after admission for (N)STEMI between 1-1-2019 and 31-08-2020Planned for follow-up at a participating PENELOPE CTRL siteHistory of T2DM and/or history of ASCVD defined as either one of:cerebrovascular disease/ event: transient ischemic attack, cerebral infarction, amaurosis fugax, retinal infarctionCoronary artery disease/ event: unstable angina pectoris, MI, ACS, coronary revascularization (coronary angioplasty or surgical procedure for coronary bypass)Peripheral artery disease (symptomatic and documented obstruction of a distal extremity artery or surgical intervention (percutaneous transluminal angioplasty, bypass or amputation)Exclusion Criteria:Pregnant and lactating womenParticipation in lipid modifying drug trials up to two years after index cardiovascular event
Source: ClinicalTrials.gov (NCT05659888). StuddyBuddy aggregates publicly available trial information.
